Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA

Published:2018-11 Issue:6 Volume:20 Page:859-870
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Biancon Giulia,Gimondi Silvia,Vendramin Antonio,Carniti Cristiana,Corradini Paolo

Funder

Associazione Italiana contro le Leucemie-linfomi e mieloma

Associazione Italiana Ricerca Cancro

Fondazione Adiuvare

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference38 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. The 39th David A. Karnofsky lecture: bench-to-bedside translation of targeted therapies in multiple myeloma;Anderson;J Clin Oncol,2012

3. Minimal residual disease in multiple myeloma: bringing the bench to the bedside;Mailankody;Nat Rev Clin Oncol,2015

4. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma;Martinez-Lopez;Blood,2014

5. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study;Roschewski;Lancet Oncol,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study;Leukemia & Lymphoma;2024-03-03

3. Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas;British Journal of Haematology;2024-01-04

4. Monitoring mutant KRAS in plasma cell-free DNA can predict disease progression in a patient with multiple myeloma: A case report;Clinica Chimica Acta;2023-11

5. Measurable residual disease in peripheral blood in myeloma: dream or reality;Current Opinion in Oncology;2023-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3